MEDX/IPILIMUMAB:MAYO results in aggressive prostate cancer <a href="http://investorshub.advfn.com/boards/read_msg.aspx?message_id=38915117" rel="nofollow" target="_blank">http://investorshub.advfn.com/boards/read_msg.aspx?message_id=38915117</a>